Babaamaajimowinan (Telling of news in different places)

Hemp industry lawsuit challenging DEA's position on CBD picks up support of 28 U.S. legislators

A bipartisan congressional coalition pushed back on the U.S. Drug Enforcement Administration’s assertion that cannabidiol and extracts derived from hemp are Schedule I substances.

Twenty-eight legislators including Sen. Rand Paul, R-Ky., Sen. Ron Wyden, D-Ore., and Rep. Jared Polis, D-Colo., on Thursday filed an amicus brief in support of the Hemp Industries Association’s lawsuit challenging the DEA’s new rule on “marihuana extracts.”


Reader Comments(0)